Abstract

To find an explanation for the reported positive effect of a dimethyl sulfoxide (DMSO) treatment on the performance of the bone scan agent technetium-(tin)-ethane-1-hydroxy-1, 1-diphosphonate, we compared the composition of the agent, prepared with and without treatment with DMSO by using high performance ion-pair chromatography (IPC). The preparation obtained with the DMSO treatment appeared to contain a larger fraction of large and highly charged polynuclear complexes than the preparation without the DMSO treatment. According to experiments by other investigators the smaller 99mTc(Sn)EHDP complexes (early eluting components in IPC) give lower bone/blood ratios than the larger ones. The results presented in this paper show that the explanation for the effect of the DMSO treatment may be that the Sn-EHDP complexes which are removed by extraction with DMSO, give relatively small 99mTc(Sn)EHDP complexes. Without these small complexes a superior bone scan agent is obtained. From experiments in which an excess of 99TcO 4 over Sn(II) was used, it was concluded that at least one of the technetium complexes contains Sn(IV). On the other hand, the absence of Sn from a late eluting technetium complex was proven.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.